THC Biomed Intl Ltd.
THCBF
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.28M
Close$
Share Statistics
| Market cap | $3.28 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | -0.36 |
| Outstanding Shares | 163,938,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -1.07 |
|---|---|
| PEG | -0.17 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
January 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About THC Biomed Intl Ltd.
35 employees
CEO: John Miller THC Biomed Intl Ltd. is a Canadian enterprise engaged in the production and sale of cannabis products for both medical and recreational consumers. Its offerings encompass a range of cannabis-infused edibles and drinks, such as beverage s...